2-Hydroxypropyl-beta-cyclodextrin: Clinical Trials

3 trials of 2-Hydroxypropyl-beta-cyclodextrin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 2, 2 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Completed 3
Phase 12Completed 2
Phase 31Completed 1

Follow 2-Hydroxypropyl-beta-cyclodextrin: new trials by email Literature Review of 2-Hydroxypropyl-beta-cyclodextrin trials Research Report on 2-Hydroxypropyl-beta-cyclodextrin

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C
VTS-270 - Niemann-Pick Disease, Type C
Phase 1 / Phase 2CompletedWashington University School of Medicine42019-02-222026-01-05
Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients
Hydroxypropyl-beta-cyclodextrin - Niemann-Pick Disease, Type C1
Phase 1 / Phase 2CompletedCyclo Therapeutics, Inc.122017-03-202021-08-10
VTS-270 to Treat Niemann-Pick Type C1 (NPC1) Disease
Parts A/B: Adrabetadex, Parts A/B: Sham Control - Niemann-Pick Disease, Type C
Phase 2 / Phase 3CompletedMandos LLC562015-10-012023-02-22

Conditions studied

Niemann-Pick Disease, Type C (3)  ·  Cognitive Dysfunction (1)  ·  Deglutition Disorders (1)  ·  Disease (1)  ·  Mobility Limitation (1)

Sponsors

Cyclo Therapeutics, Inc. (1)  ·  Mandos LLC (1)  ·  Washington University School of Medicine (1)

Countries

United Kingdom (2)  ·  United States (2)  ·  Australia (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  New Zealand (1)  ·  Singapore (1)  ·  Spain (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)

Top investigators

Patricia I Dickson, MD (1)  ·  Reena Sharma, MB BS (1)

Results publications

PMID 37670901, PMID 40525490

NIH funding

2015 (1), U01HD090845 (1)